Anaveon is a late pre-clinical phase biotech based in Basel, Switzerland. It focuses on the development of next generation IL-2 based therapeutic antibodies for tumor immunotherapy in melanoma, kidney carcinoma and lung cancer.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2017
Key business